Enhance the glaucoma picture Measure ganglion cell function
PhNR testing with the RETeval® is a vital tool for managing patients with glaucoma and other optic nerve diseases with objective assessments of ganglion health.
O diagnóstico precoce é essencial para evitar a perda da visão devido à degeneração futura das células ganglionares.
However, glaucoma is often challenging to diagnose and manage. Testing such as perimetry and OCT imaging are standard of care, but are all too often hampered by media opacities (imaging for cup-to-disc-ratio), unspecific testing methods (IOP), or subjective and bothersome to complete (visual field test).
PhNR significa Photopic Negative Response (resposta negativa fotópica) e é um teste eletrorretinográfico para analisar o funcionamento das células ganglionares.
During the Photopic Negative Response test with full-field flash ERG, the retina is illuminated with a red flash on a blue background under light-adapted conditions. This last negative peak is derived from the ganglion cells and their axons and is generally used to evaluate subjects for Glaucoma.
The PhNR response from ERG is described by a time (implicit time) and amplitude. For glaucoma diagnosis and management, several parameters are given as the disease itself is complex [37].
The RETeval PhNR test objectively measures ganglion cells function by evaluating the electrical activity of the cells to a light stimulus. Knowing how the ganglion cells are functioning may assists in detecting and monitoring glaucomatous changes in patients.
O teste RETeval oferece alta objetividade e repetibilidade, é independente das opacidades do meio e é adequado também para pacientes com habilidades motoras e cognitivas reduzidas [31][32][34].

Real time pupillography continuously adjusts for pupil size and can be used for patients in any stage of dilation

Our patented, non-invasive Sensor Strip skin electrodes mean that no corneal electrodes are required.

The handheld RETeval device is light, portable, and easy to use. Technicians can be trained in minutes.
Espera-se que o dispositivo RETeval detecte alterações com um alto grau de precisão.
Kita et al. have compared seven parameters of the RETeval PhNR test for their ability to differentiate between early or moderate glaucoma from a healthy control group. In this study, high accuracy of the PhNR test was found [38].
(Early glaucoma)
Analisar a amplitude do PhNR no nível mínimo
(Moderate glaucoma)
Analisar a relação W do PhNR
PhNR testing with the RETeval Device provides sensitive, objective monitoring of retinal changes for more informed follow-up, even where no changes in visual field or RNFL could be detected
Hui et al. detectaram melhorias na função interna da retina após o tratamento com nicotinamida, onde não foram observadas melhorias no campo visual ou RNFL [39].
Nosso novo algoritmo proporciona uma melhoria significativa na variabilidade do teste/reteste, levando a uma melhor capacidade de acompanhar o progresso do paciente ao longo do tempo. Além disso, o intervalo de referência é mais estreito, levando a uma maior capacidade de auxiliar na detecção da função anormal das células ganglionares.
O protocolo está em conformidade com o ISCEV*, usa as configurações de estímulos mais eficazes e está disponível em diferentes configurações que permitem que os médicos façam ajustes de acordo com as condições do paciente (opções de teste curto e longo, midriático e não midriático). *Sociedade Internacional de Eletrofisiologia Clínica da Visão
*International Society for Clinical Electrophysiology of Vision
O relatório do teste PhNR fornece a amplitude e o tempo implícito das duas primeiras ondas.
The typical PhNR values such as amplitude and implicit time at the minimum are shown below the curves. For the support of a differential glaucoma diagnosis and management, other parameters have been analyzed by researchers, such as the W-ratio, which is calculated from the PhNR, a-, and b-wave amplitudes.
Our updated PhNR reports put all the criteria you need to consider dysfunction front and center, allowing you to make better clinical calls for your patients while saving valuable time.
Obter mais informações ou solicitar uma demonstração ou orçamento do dispositivo RETeval
Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.
Substance Tables:
The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing.
RETeval and RETevet Devices
| Substance | CAS # | Type | Listed as causing: |
| Nickel | 7440-02-0 | 1 | Cancer |
| Acrylonitrile | 107-13-1 | 2 | |
| Ethylbenzine | 100-41-4 | 2 | |
| Crystaline Silica | 14808-60-7 | 1 | |
| Lead | 7439-92-1 | 1 | Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity |
| Methylene Chloride | 75-09-2 | 2 | Cancer Female Reproductive Toxicity |
| Bisphenol A | 80-05-7 | 2 | |
| N-Hexane | 110-54-3 | 2 | Male Reproductive Toxicity |
